Document Detail


Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience.
MedLine Citation:
PMID:  17509947     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Few trials report event-adjudication procedures in detail. Using data from the ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) study, we compared the impact on event-rates of an adjudication strategy based on systematic screening of all reported serious adverse events (SAEs) with a strategy based on investigator diagnoses. The final diagnosis was always made by a critical events committee (CEC) using standard criteria. METHODS: ACTION randomized 7665 patients with stable angina to either nifedipine or placebo. Pre-specified events included acute or procedural myocardial infarction (MI), refractory angina, heart failure and debilitating stroke. Clinically related SAEs including in-hospital procedures were combined into episodes independent from the investigator diagnoses entered on SAE reports. All fatal episodes and those episodes suggestive of pre-specified events were adjudicated by the CEC. RESULTS: During follow-up, 17,081 episodes were reported in 5312 patients. The SAE descriptions ruled out the occurrence of a pre-specified event in 28%. The remaining 72% were adjudicated by the CEC and 616 cases of MI, 361 of refractory angina, 275 of heart failure and 190 of debilitating stroke were diagnosed (total=1442). Had adjudication by the CEC been limited to the 3924 episodes (2397 patients) that were fatal or for which the investigator had reported any of the diagnoses mentioned, 98 cases of MI, 35 of refractory angina, 81 of heart failure and 14 of debilitating stroke would have been missed (total=228). CONCLUSION: Both the diagnostic criteria used and the adjudication process determine event-rates and conclusions about treatment effects in clinical trials. Published trial reports should always state if event-adjudication was independent of the diagnoses of investigators, and if all events of interest were adjudicated or only the first one.
Authors:
Bridget-Anne Kirwan; Jacobus Lubsen; Sophie de Brouwer; Nicolas Danchin; Alexander Battler; Antonio Bayes de Luna; Peter H J M Dunselman; Stephen Glasser; Peter J Koudstaal; George Sutton; Frederik J van Dalen; Philip A Poole-Wilson;
Related Documents :
8034867 - Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in as...
23729007 - Two chromosome 9p21 haplotype blocks distinguish between coronary artery disease and my...
20034957 - The prevalence and outcome of excess body weight among middle eastern patients presenti...
8281697 - Quantitative two-dimensional echocardiographic measurements are major predictors of adv...
12047047 - A novel cardioprotective agent, jtv-519, is abolished by nitric oxide synthase inhibito...
8407007 - Somatic and social prognosis of patients with angina pectoris and normal coronary arter...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2007-04-19
Journal Detail:
Title:  Contemporary clinical trials     Volume:  28     ISSN:  1551-7144     ISO Abbreviation:  -     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-10-08     Completed Date:  2008-01-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101242342     Medline TA:  Contemp Clin Trials     Country:  United States    
Other Details:
Languages:  eng     Pagination:  720-9     Citation Subset:  IM    
Affiliation:
SOCAR Research, PO Box 2564, CH-1260 Nyon, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Coronary Artery Disease / drug therapy*
Humans
Nifedipine / administration & dosage,  pharmacology,  therapeutic use
Placebos
Sentinel Surveillance*
Treatment Outcome
Vasodilator Agents / administration & dosage,  pharmacology,  therapeutic use
Chemical
Reg. No./Substance:
0/Placebos; 0/Vasodilator Agents; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Next Document:  Feasibility study for cell electroporation detection and separation by means of dielectrophoresis.